Crohn’s disease – media

New Simplified Formula Tested for Assessment of MRI in Crohn’s Disease

A Spanish research team who gained fame for introducing the MRI-based formula that grades the activity of luminal Crohn’s disease in 2011, recently developed and tested a fresh, easier adaptation of their MRI score that leads to a swifter assessment.
- Source: MDEdge
- 629
- July 25, 2018
Crohn’s disease medtech Researches
Janssen Enters Into Worldwide Collaboration With Theravance Biopharma For Oral, Pan-JAK Inhibitor Drug Candidate For The Treatment Of Inflammatory Bowel Disease

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today their entry into a worldwide collaboration with an affiliate of Theravance Biopharma, Inc. to develop TD-1473, a first-in-class oral, gastrointestinal (GI) restricted pan-Janus kinase (JAK) inhibitor for the treatment of inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis (UC).
- Source: prnewswire
- 598
- February 11, 2018
Crohn’s disease IBD Janssen Johnson & Johnson ulcerative colitis
Two Former Receptos Execs Launch New San Diego Biotech Startup With $100M

Gossamer Bio is launching with $100 million in seed financing and two biotech heavy hitters as leadership.
- Source: drugdu
- 484
- January 10, 2018
Crohn’s disease Market Views multiple sclerosis Series ulcerative colitis

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.